Ballicules › Drugs › Ivabradine
Pronunciation: eye-VAB-ra-deen (KOR-lan-or)
Mechanism of action: Ivabradine ballicule
Visual mnemonic: Ivabradine mascot“Ivy braids in Coral”
What it is Selective funny-current inhibitor in the sinus node; heart failure and inappropriate sinus tachycardia.
Why this one It slows the heart without lowering blood pressure or contractility, so it works when beta blockade is maximal or not tolerated.
What limits it Fetal toxicity, and it only works in sinus rhythm. Luminous phenomena; CYP3A4-dependent.
Molecular structure: Ivabradine
FDA-approved for
FDA label
Read the full label on DailyMed ↗
FDA dosing Population Start Target Max
Stable symptomatic heart failure (reduce hospitalization) Adult 5 mg BID (2.5 mg BID if vulnerable or conduction defect) titrate to resting HR 50-60 bpm 7.5 mg BID
Titration Reassess after 2 weeks, then adjust by 2.5 mg BID based on resting heart rate.
Renal No adjustment for CrCl ≥15 mL/min; no data if CrCl <15 mL/min.
Hepatic No adjustment in mild-moderate impairment; contraindicated in severe (Child-Pugh C).
Instructions Take twice daily with food Oral solution may be used in adults unable to swallow tablets Discontinue if atrial fibrillation develops
Available strengths
tab 5, 7.5 mgsol 5 mg/5 mL
Contraindications Acute decompensated heart failure Clinically significant hypotension Sick sinus syndrome, sinoatrial block, or 3rd-degree AV block (unless functioning demand pacemaker) Clinically significant bradycardia Severe hepatic impairment Pacemaker dependence (heart rate maintained exclusively by pacemaker) Concomitant strong CYP3A4 inhibitors
Cautions Fetal toxicity — use effective contraception Increases risk of atrial fibrillation — monitor rhythm Bradycardia and conduction disturbances Not recommended in 2nd-degree AV block
Adverse reactions Bradycardia Hypertension Atrial fibrillation Luminous phenomena (phosphenes)
Pregnancy May cause fetal harm (cardiac teratogenicity in animals); advise effective contraception.
Lactation Undefined
Cost Ivabradine (CORLANOR)
What pharmacies pay · NADAC 9/30/26
Strength #/mo generic $ CostPlus 5 mg tab 60 BID $45.64/mo offered 7.5 mg tab 60 BID $38.40/mo offered 5 mg/5 mL sol per unit not offered
Generic entry 2021
Principal risk Fetal toxicity; it works only in sinus rhythm
Classes and tags
Clinical profile
Therapeutic safety burden 1 / 4
Overdose danger 2 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 1 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 1 / 4
Legacy pregnancy category Unknown / historical label unavailable
Defining liability Generally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Open Ivabradine in the interactive console ↗
Memory aids: interaction avatars
Open Ivabradine in the interactive console ↗